Oncology PracticeResponse to preop immunotherapy predicts survival in early NSCLCSeptember 30, 2021Lung Cancer
Oncology PracticeStudies confirm survival benefit with postchemoradiotherapy consolidation in NSCLCSeptember 29, 2021Lung Cancer
Oncology PracticeOnce daily poziotinib shows efficacy in non–small cell lung cancerSeptember 28, 2021Lung Cancer
Oncology PracticeAtezolizumab plus chemotherapy superior to best supportive care in early lung cancerSeptember 28, 2021Lung Cancer
Oncology PracticeStudy supports chemotherapy with immunotherapy for some never-smokers with lung cancerSeptember 28, 2021Lung Cancer
Oncology PracticeFirst-line bevacizumab-osimertinib disappoint in EGFR-mutant NSCLCSeptember 24, 2021Lung Cancer
Oncology PracticeCombination treatment shows promise for men with advanced prostate cancerSeptember 24, 2021Genitourinary Cancer
Hematology NewsLong COVID appears to ‘impair’ survival in cancer patientsSeptember 23, 2021COVID-19 Updates
Hematology NewsRare hematologic malignancy may first present to a dermatologistSeptember 23, 2021Rare DiseasesMixed Topics
Oncology PracticeDatopotamab deruxtecan for advanced NSCLC encouraging so farSeptember 23, 2021Lung Cancer
Oncology PracticeTULIP trial shows extended survival in HER2+ metastatic breast cancerSeptember 23, 2021Breast Cancer
Oncology PracticeStudy supports add-on therapy for germline and wildtype BRCA mutationsSeptember 22, 2021Breast Cancer
Oncology PracticeMost community-based oncologists skip biomarker testingSeptember 21, 2021Lung CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
